BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 30185813)

  • 21. Role of JMJD6 in Breast Tumourigenesis.
    Poulard C; Rambaud J; Lavergne E; Jacquemetton J; Renoir JM; Trédan O; Chabaud S; Treilleux I; Corbo L; Le Romancer M
    PLoS One; 2015; 10(5):e0126181. PubMed ID: 25951181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knockout of KDM3A in MDA-MB-231 breast cancer cells inhibits tumor malignancy and promotes apoptosis.
    Han Y; Maimaiti N; Sun Y; Yao J
    J Mol Histol; 2024 Feb; 55(1):139-148. PubMed ID: 38165573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer.
    Chen B; Wang J; Dai D; Zhou Q; Guo X; Tian Z; Huang X; Yang L; Tang H; Xie X
    J Exp Clin Cancer Res; 2017 May; 36(1):65. PubMed ID: 28494797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histone demethylase JMJD6 regulates cellular migration and proliferation in adipose-derived mesenchymal stem cells.
    Shen C; Quan Q; Yang C; Wen Y; Li H
    Stem Cell Res Ther; 2018 Aug; 9(1):212. PubMed ID: 30092848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. KDM4B-regulated unfolded protein response as a therapeutic vulnerability in
    Wang W; Oguz G; Lee PL; Bao Y; Wang P; Terp MG; Ditzel HJ; Yu Q
    J Exp Med; 2018 Nov; 215(11):2833-2849. PubMed ID: 30266800
    [No Abstract]   [Full Text] [Related]  

  • 26. Epigenome screening highlights that JMJD6 confers an epigenetic vulnerability and mediates sunitinib sensitivity in renal cell carcinoma.
    Zhang C; Lu X; Huang J; He H; Chen L; Liu Y; Wang H; Xu Y; Xing S; Ruan X; Yang X; Chen L; Xu D
    Clin Transl Med; 2021 Feb; 11(2):e328. PubMed ID: 33634984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The autophagy inhibitor chloroquine targets cancer stem cells in triple negative breast cancer by inducing mitochondrial damage and impairing DNA break repair.
    Liang DH; Choi DS; Ensor JE; Kaipparettu BA; Bass BL; Chang JC
    Cancer Lett; 2016 Jul; 376(2):249-58. PubMed ID: 27060208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DEPDC1, negatively regulated by miR-26b, facilitates cell proliferation via the up-regulation of FOXM1 expression in TNBC.
    Zhang L; Du Y; Xu S; Jiang Y; Yuan C; Zhou L; Ma X; Bai Y; Lu J; Ma J
    Cancer Lett; 2019 Feb; 442():242-251. PubMed ID: 30419349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of JMJD6 expression reduces the proliferation, migration and invasion of neuroglioma stem cells.
    Zhou DX; Zhou D; Zhan SQ; Wang P; Qin K; Gan W; Lin XF
    Neoplasma; 2017; 64(5):700-708. PubMed ID: 28592121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenesis and micro-anatomic characterization of a cell-adapted mutant foot-and-mouth disease virus in cattle: Impact of the Jumonji C-domain containing protein 6 (JMJD6) and route of inoculation.
    Lawrence P; Pacheco J; Stenfeldt C; Arzt J; Rai DK; Rieder E
    Virology; 2016 May; 492():108-17. PubMed ID: 26914509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of Jumonji C-domain containing protein 6 (JMJD6) in infectivity of foot-and-mouth disease virus.
    Lawrence P; Rai D; Conderino JS; Uddowla S; Rieder E
    Virology; 2016 May; 492():38-52. PubMed ID: 26896934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/β-catenin pathway in non-small cell lung cancer.
    Zhang Z; Yang Y; Zhang X
    Life Sci; 2017 Nov; 188():163-171. PubMed ID: 28882645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation.
    Wright HJ; Hou J; Xu B; Cortez M; Potma EO; Tromberg BJ; Razorenova OV
    Proc Natl Acad Sci U S A; 2017 Aug; 114(32):E6556-E6565. PubMed ID: 28739932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination of the novel histone deacetylase inhibitor YCW1 and radiation induces autophagic cell death through the downregulation of BNIP3 in triple-negative breast cancer cells in vitro and in an orthotopic mouse model.
    Chiu HW; Yeh YL; Wang YC; Huang WJ; Ho SY; Lin P; Wang YJ
    Mol Cancer; 2016 Jun; 15(1):46. PubMed ID: 27286975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of the Epigenetic Modifier JMJD6 in Tumor Development and Regulation of Immune Response.
    Wang K; Yang C; Li H; Liu X; Zheng M; Xuan Z; Mei Z; Wang H
    Front Immunol; 2022; 13():859893. PubMed ID: 35359945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Near-infrared photothermal therapy using EGFR-targeted gold nanoparticles increases autophagic cell death in breast cancer.
    Zhang M; Kim HS; Jin T; Moon WK
    J Photochem Photobiol B; 2017 May; 170():58-64. PubMed ID: 28390259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.
    Kim S; Lee J; Jeon M; Lee JE; Nam SJ
    Oncotarget; 2016 Jan; 7(2):1544-58. PubMed ID: 26637807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. JMJD6 is a tumorigenic factor and therapeutic target in neuroblastoma.
    Wong M; Sun Y; Xi Z; Milazzo G; Poulos RC; Bartenhagen C; Bell JL; Mayoh C; Ho N; Tee AE; Chen X; Li Y; Ciaccio R; Liu PY; Jiang CC; Lan Q; Jayatilleke N; Cheung BB; Haber M; Norris MD; Zhang XD; Marshall GM; Wang JY; Hüttelmaier S; Fischer M; Wong JWH; Xu H; Perini G; Dong Q; George RE; Liu T
    Nat Commun; 2019 Jul; 10(1):3319. PubMed ID: 31346162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insights into Jumonji C-domain containing protein 6 (JMJD6): a multifactorial role in foot-and-mouth disease virus replication in cells.
    Lawrence P; Rieder E
    Virus Genes; 2017 Jun; 53(3):340-351. PubMed ID: 28364140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myoferlin regulates cellular lipid metabolism and promotes metastases in triple-negative breast cancer.
    Blomme A; Costanza B; de Tullio P; Thiry M; Van Simaeys G; Boutry S; Doumont G; Di Valentin E; Hirano T; Yokobori T; Gofflot S; Peulen O; Bellahcène A; Sherer F; Le Goff C; Cavalier E; Mouithys-Mickalad A; Jouret F; Cusumano PG; Lifrange E; Muller RN; Goldman S; Delvenne P; De Pauw E; Nishiyama M; Castronovo V; Turtoi A
    Oncogene; 2017 Apr; 36(15):2116-2130. PubMed ID: 27775075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.